ADVANCED PROTEOME THERAPEUTICS CORP. Inactive Instrument
Advanced Proteome Therapeutics Corp. Share Price Other OTC
Equities
CA0076281009
Investment Holding Companies
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2021 | - | Sales 2022 | - | Capitalization | 46.48L 39Cr |
|---|---|---|---|---|---|
| Net income 2021 | -10L -8.33Cr | Net income 2022 | - 0 | EV / Sales 2021 | - |
| Net cash position 2021 | 3L 2.7Cr | Net cash position 2022 | 31.61T 26.34L | EV / Sales 2022 | - |
| P/E ratio 2021 |
-4.85
x | P/E ratio 2022 |
6.03
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.84% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16/18/16 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10/09/10 |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20/18/20 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21/22/21 |
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.
Sector
Investment Holding Companies
Calendar
25/06/2024
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +198.00% | 712.89Cr | |
| +2.19% | 98Cr | |
| +41.91% | 87Cr | |
| +25.43% | 82Cr | |
| +1.77% | 66Cr | |
| +5.92% | 65Cr | |
| -.--% | 60Cr | |
| +3.61% | 50Cr | |
| -.--% | 50Cr |
